Caudill Cortney 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-01+9,326→ 17,000 total - Sale
Common Stock
2025-11-01$65.19/sh−4,263$277,905→ 12,737 total - Exercise/Conversion
Restricted Stock Units
2025-11-01−9,326→ 18,651 totalExercise: $0.00→ Common Stock (9,326 underlying)
Footnotes (2)
- [F1]The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.